Both XELIRI And TEGAFIRI Togetherwith Bevacizumab are Effective for Recurrent or Metastatic Colorectal Cancer: A Real-Life Experience

Abstract

Both XELIRI And TEGAFIRI Together with Bevacizumab are Effective for Recurrent or Metastatic Colorectal Cancer: A Real-Life Experience Hsu TC and Liao PN Department of Surgery, Division of Colon & Rectal Surgery, Taipei Mackay Memorial Hospital, Taipei, Taiwan ; Department of Medicine, Mackay Medical College, New Taipei City, Taiwan Department of physician, Taipei Mackay Memorial Hospital, Taipei, Taiwan